Golf & Imtesty, this is precisely why I am not selling my shares. The science is too exciting. I still believe this is breakthrough science leading to new approaches in medicine.

I think we have clearly flushed out the problem, at least in management terms.

It is befuddling that funding is not flowing into this company like an overflowing river.

Why are the insiders, Hepa, Ori, Eastern not stepping up to the plate especially since Covid could be a quick trial with apabetalone providing new benefits in terms of heart protection?

What is holding them back? They are the people in the know and with the most to gain.

The price is good for now because I can still buy from time to time and I like that because I believe with constant good science evidence at some point something has got to give in a positive way. It just has to. Somebody is going to get apabetalone to market and I think somebody will turn Zenith into a business.

I guess I still believe in the Easter Bunny   :)

GLTA

Toinv